Skip to main content
Clinical Trials/CTRI/2021/05/033326
CTRI/2021/05/033326
Not yet recruiting
Phase 2

A Randomised open controlled clinical trial to evaluate the efficacy of Indrayavadi yoga in Asrugdara with special reference to Dysfunctional uterine bleeding (DUB).

Priyanka Dilipkumar Sahu0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Sponsor
Priyanka Dilipkumar Sahu
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Priyanka Dilipkumar Sahu

Eligibility Criteria

Inclusion Criteria

  • 1\.Diagnosed patients of DUB having age group 20 to 45 Years .
  • 2\.Selection irrespective of marital status, parity, socio\-economic status.
  • 3\.Patient having sign and symptoms of Asrugdara.
  • 4\.Excessive bleeding more than two consecutive cycles.
  • 5\.Those having Intermenstrual bleeding
  • 6\.Excessive bleeding per vagina during menstruation either in amount or in duration or both.
  • 7\.Hb \> 8%gm/dl.

Exclusion Criteria

  • 1\.Patients having blood dyscrasias
  • 2\.Major systemic disease likely to influence menstrual cycle like HTN , DM , TB , HIV , Thyroid, Kidney
  • 3\.Known Patients of malignancy, cervical erosion, polyp, adenomyosis, pelvic endometriosis, tubo\-ovarian mass , PCOD.
  • 4\.Known case of structural anomalies of genital organs.
  • 5\.Patients using IUCD.
  • 6\.Patients undergoing treatment for any other serious illness.
  • 7\.Those having postmenopausal bleeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials